Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation

This is a reprint of articles from the Special Issue published online in the open access journal Viruses (ISSN 1999-4915) entitled “Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation”.

Gorde:
Xehetasun bibliografikoak
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2024
Gaiak:
Sarrera elektronikoa:ONIX_20240514_9783725800506_85
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
_version_ 1869526438937362432
collection Directory of Open Access Books
description This is a reprint of articles from the Special Issue published online in the open access journal Viruses (ISSN 1999-4915) entitled “Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation”.
format Online
id doab-20.500.12854ir-137483
institution Directory of Open Access Books
language eng
publishDate 2024
publishDateRange 2024
publishDateSort 2024
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1374832024-05-14T13:15:31Z Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation Brogi, Simone dialysis end-stage kidney disease hepatitis C virus sofosbuvir sustained viral response carbapenem-resistant Pseudomonas aeruginosa bacteriophage hydrogel thermal injury model histopathology foot-and-mouth disease virus (FMDV) RNA-dependent RNA polymerase (RdRp) 3D polymerase (3Dpol) small molecule virtual screening antiviral cell-based assay antiviral agent PSP HIV proteomics cofilin-1 PKR IRE1α UPR Zika virus peptide antiviral DV2 peptide dengue virus flavivirus deep learning SARS-CoV-2 Mpro transfer learning drug development natural compound virus picornavirus enterovirus edible plant PI4KB influenza neuraminidase inhibitors noncompetitive inhibition ligand docking screening pitfalls screening problems HIV-1 gp120 V3 loop chemokine receptor CXCR4 molecular recognition D-peptide HIV-1 entry antiviral agents coronaviruses viral entry antimicrobial coronavirus abietane dehydroabietylamine phenol phthalimide COVID-19 microscale thermophoresis SLC6A20 amino acid transporter Dengue virus natural compounds NS5 protein antiviral activity heterocycles natural products Structure Activity Relationship (SAR) synthetic methods SARS-CoV-2 NSP3 macrodomain-I medicinal compounds computational biology n/a thema EDItEUR::M Medicine and Nursing This is a reprint of articles from the Special Issue published online in the open access journal Viruses (ISSN 1999-4915) entitled “Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation”. 2024-05-14T13:15:23Z 2024-05-14T13:15:23Z 2024 book ONIX_20240514_9783725800506_85 9783725800506 9783725800490 https://directory.doabooks.org/handle/20.500.12854/137483 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/8640 https://mdpi.com/books/pdfview/book/8640 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-0049-0 10.3390/books978-3-7258-0049-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725800506 9783725800490 282 open access
spellingShingle dialysis
end-stage kidney disease
hepatitis C virus
sofosbuvir
sustained viral response
carbapenem-resistant
Pseudomonas aeruginosa
bacteriophage
hydrogel
thermal injury model
histopathology
foot-and-mouth disease virus (FMDV)
RNA-dependent RNA polymerase (RdRp)
3D polymerase (3Dpol)
small molecule
virtual screening
antiviral cell-based assay
antiviral agent
PSP
HIV
proteomics
cofilin-1
PKR
IRE1α
UPR
Zika virus
peptide
antiviral
DV2 peptide
dengue virus
flavivirus
deep learning
SARS-CoV-2 Mpro
transfer learning
drug development
natural compound
virus
picornavirus
enterovirus
edible plant
PI4KB
influenza
neuraminidase inhibitors
noncompetitive inhibition
ligand docking
screening pitfalls
screening problems
HIV-1 gp120 V3 loop
chemokine receptor CXCR4
molecular recognition
D-peptide
HIV-1 entry
antiviral agents
coronaviruses
viral entry
antimicrobial
coronavirus
abietane
dehydroabietylamine
phenol
phthalimide
COVID-19
microscale thermophoresis
SLC6A20 amino acid transporter
Dengue virus
natural compounds
NS5 protein
antiviral activity
heterocycles
natural products
Structure Activity Relationship (SAR)
synthetic methods
SARS-CoV-2
NSP3
macrodomain-I
medicinal compounds
computational biology
n/a
thema EDItEUR::M Medicine and Nursing
Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title_full Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title_fullStr Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title_full_unstemmed Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title_short Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation
title_sort novel antiviral agents synthesis molecular modelling studies and biological investigation
topic dialysis
end-stage kidney disease
hepatitis C virus
sofosbuvir
sustained viral response
carbapenem-resistant
Pseudomonas aeruginosa
bacteriophage
hydrogel
thermal injury model
histopathology
foot-and-mouth disease virus (FMDV)
RNA-dependent RNA polymerase (RdRp)
3D polymerase (3Dpol)
small molecule
virtual screening
antiviral cell-based assay
antiviral agent
PSP
HIV
proteomics
cofilin-1
PKR
IRE1α
UPR
Zika virus
peptide
antiviral
DV2 peptide
dengue virus
flavivirus
deep learning
SARS-CoV-2 Mpro
transfer learning
drug development
natural compound
virus
picornavirus
enterovirus
edible plant
PI4KB
influenza
neuraminidase inhibitors
noncompetitive inhibition
ligand docking
screening pitfalls
screening problems
HIV-1 gp120 V3 loop
chemokine receptor CXCR4
molecular recognition
D-peptide
HIV-1 entry
antiviral agents
coronaviruses
viral entry
antimicrobial
coronavirus
abietane
dehydroabietylamine
phenol
phthalimide
COVID-19
microscale thermophoresis
SLC6A20 amino acid transporter
Dengue virus
natural compounds
NS5 protein
antiviral activity
heterocycles
natural products
Structure Activity Relationship (SAR)
synthetic methods
SARS-CoV-2
NSP3
macrodomain-I
medicinal compounds
computational biology
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet dialysis
end-stage kidney disease
hepatitis C virus
sofosbuvir
sustained viral response
carbapenem-resistant
Pseudomonas aeruginosa
bacteriophage
hydrogel
thermal injury model
histopathology
foot-and-mouth disease virus (FMDV)
RNA-dependent RNA polymerase (RdRp)
3D polymerase (3Dpol)
small molecule
virtual screening
antiviral cell-based assay
antiviral agent
PSP
HIV
proteomics
cofilin-1
PKR
IRE1α
UPR
Zika virus
peptide
antiviral
DV2 peptide
dengue virus
flavivirus
deep learning
SARS-CoV-2 Mpro
transfer learning
drug development
natural compound
virus
picornavirus
enterovirus
edible plant
PI4KB
influenza
neuraminidase inhibitors
noncompetitive inhibition
ligand docking
screening pitfalls
screening problems
HIV-1 gp120 V3 loop
chemokine receptor CXCR4
molecular recognition
D-peptide
HIV-1 entry
antiviral agents
coronaviruses
viral entry
antimicrobial
coronavirus
abietane
dehydroabietylamine
phenol
phthalimide
COVID-19
microscale thermophoresis
SLC6A20 amino acid transporter
Dengue virus
natural compounds
NS5 protein
antiviral activity
heterocycles
natural products
Structure Activity Relationship (SAR)
synthetic methods
SARS-CoV-2
NSP3
macrodomain-I
medicinal compounds
computational biology
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20240514_9783725800506_85